Trinity Biotech PLC (TRIB)
1.30
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
1.30
0.00 (0.00%)
After-Hours: 07:23
Trinity Biotech Debt to Equity Ratio: -3.106 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.106 |
| June 30, 2024 | -2.754 |
| March 31, 2024 | -3.221 |
| December 31, 2023 | -2.291 |
| September 30, 2023 | -3.116 |
| June 30, 2023 | -4.757 |
| March 31, 2023 | -9.572 |
| December 31, 2022 | -26.77 |
| September 30, 2022 | 8.731 |
| June 30, 2022 | 3.639 |
| March 31, 2022 | -12.16 |
| December 31, 2021 | -261.17 |
| September 30, 2021 | 102.67 |
| June 30, 2021 | -167.72 |
| March 31, 2021 | -661.77 |
| December 31, 2020 | -38.58 |
| September 30, 2020 | 11.75 |
| June 30, 2020 | -116.44 |
| March 31, 2020 | 107.01 |
| December 31, 2019 | 17.40 |
| September 30, 2019 | 2.103 |
| June 30, 2019 | 2.093 |
| March 31, 2019 | 1.855 |
| December 31, 2018 | 1.847 |
| September 30, 2018 | 1.205 |
| Date | Value |
|---|---|
| June 30, 2018 | 1.427 |
| March 31, 2018 | 1.447 |
| December 31, 2017 | 1.426 |
| September 30, 2017 | 0.8959 |
| June 30, 2017 | 0.8913 |
| March 31, 2017 | 0.8736 |
| December 31, 2016 | 0.8483 |
| September 30, 2016 | 0.4817 |
| June 30, 2016 | 0.471 |
| March 31, 2016 | 0.471 |
| December 31, 2015 | 0.4279 |
| September 30, 2015 | 0.4695 |
| June 30, 2015 | 0.5322 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.0002 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-661.77
Minimum
Mar 2021
107.01
Maximum
Mar 2020
-53.11
Average
-3.169
Median
Debt to Equity Ratio Benchmarks
| Amarin Corp PLC | 0.00 |
| DBV Technologies SA | -- |
| Ascendis Pharma AS | -8.104 |
| Cellectis SA | 0.3579 |
| Adaptimmune Therapeutics PLC | 0.6234 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 97.45M |
| Total Liabilities (Quarterly) | 123.79M |
| Shareholders Equity (Quarterly) | -26.34M |
| Current Ratio | 1.642 |
| Net Debt Paydown Yield | -53.20% |